1 recruiting, 1 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Suspended 1 |
| Phase 1 | 1 | Suspended 1 |
Follow Refractory Indolent B-Cell Non-Hodgkin Lymphoma: new trials by email Literature Review of Refractory Indolent B-Cell Non-Hodgkin Lymphoma trials Research Report on Refractory Indolent B-Cell Non-Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 / Phase 2 | Suspended | Fred Hutchinson Cancer Center | 33 | 2025-12-27 | 2026-09-11 |
| Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma Computed Tomography, Endoscopic Procedure, Involved-site Radiation Therapy (3 Fractions) - Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma | Phase 2 | Recruiting | Mayo Clinic | 112 | 2024-05-15 | 2026-04-22 |
Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Magnetic Resonance Spectroscopy (2) · Biopsy (1) · Endoscopy (1) · Leukapheresis (1) · Phantoms, Imaging (1) · Spinal Puncture (1) · X-Rays (1)
Fred Hutchinson Cancer Center (1) · Mayo Clinic (1)
United States (2)